Você está na página 1de 1

76062 Federal Register / Vol. 70, No.

245 / Thursday, December 22, 2005 / Notices

Dated: December 16, 2005. DEPARTMENT OF HEALTH AND The meeting will be open to the
Anna Snouffer, HUMAN SERVICES public as indicated below, with
Acting Director, Office of Federal Advisory attendance limited to space available.
Committee Policy, NIH. National Institutes of Health Individuals who plan to attend and
[FR Doc. 05–24379 Filed 12–21–05; 8:45 am] need special assistance, such as sign
National Heart, Lung, and Blood
BILLING CODE 4140–01–M Institute; Notice of Closed Meeting language interpretation or other
reasonable accommodations, should
Pursuant to section 10(d) of the notify the Contact Person listed below
DEPARTMENT OF HEALTH AND Federal Advisory Committee Act, as in advance of the meeting.
HUMAN SERVICES amended (5 U.S.C. Appendix 2), notice
The meeting will be closed to the
is hereby given of the following
meeting. public in accordance with the
National Institutes of Health
The meeting will be closed to the provisions set forth in sections
National Heart, Lung, and Blood public in accordance with the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Institute; Notice of Closed Meeting provisions set forth in sections as amended. The grant applications and
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., the discussions could disclose
Pursuant to section 10(d) of the as amended. The grant applications and confidential trade secrets or commercial
Federal Advisory Committee Act, as the discussions could disclose property such as patentable material,
amended (5 U.S.C. Appendix 2), notice confidential trade secrets or commercial and personal information concerning
is hereby given of the following property such as patentable material, individuals associated with the grant
meeting. and personal information concerning applications, the disclosure of which
The meeting will be closed to the individuals associated with the grant would constitute a clearly unwarranted
public in accordance with the applications, the disclosure of which invasion of personal privacy.
provisions set forth in sections would constitute a clearly unwarranted
Name of Committee: National Advisory
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., invasion of personal privacy.
Council for Biomedical Imaging and
as amended. The grant applications and Name of Committee: National Heart, Lung, Bioengineering.
the discussions could disclose and Blood Institute Special Emphasis Panel, Date: January 25, 2006.
confidential trade secrets or commercial Research Program Project (P01).
Open: 8 a.m. to 12 p.m.
Date: January 12, 2006.
property such as patentable material, Time: 1 p.m. to 5 p.m. Agenda: Report from the Institute Director
and personal information concerning Agenda: To review and evaluate grant and other Institute Staff.
individuals associated with the grant applications. Place: Bethesda North Hotel and
applications, the disclosure of which Place: National Institutes of Health, 6701 Conference Center, 5701 Marinelli Road,
would constitute a clearly unwarranted Rockledge Drive, Bethesda, MD 20892, North Bethesda, MD 20852.
invasion of personal privacy. (Telephone Conference Call). Closed: 1 p.m. to 4:30 p.m.
Contact Person: Irina Gordienko, PhD, Agenda: To review and evaluate grant
Name of Committee: National Heart, Lung, Division of Extramural Affairs, National applications.
and Blood Institute Special Emphasis Panel, Heart, Lung, and Blood Institute, National
Place: Bethesda North Hotel and
Mentored Clinical Scientist (K08) Award. Institutes of Health, 6701 Rockledge Drive,
Room 7180, MSC 7924, Bethesda, MD 20892, Conference Center, 5701 Marinelli Road,
Date: December 20, 2005.
301–435–0725, gordieni@nhlbi.nih.gov. North Bethesda, MD 20852.
Time: 10 am to 12 pm
(Catalogue of Federal Domestic Assistance Contact Person: Anthony Demsey, Ph.D.,
Agenda: To review and evaluate grant
Program Nos. 93.233, National Center for Director, Office of Extramural Policy,
applications.
Sleep Disorders Research; 93.837, Heart and National Institute of Biomedical Imaging and
Place: National Institutes of Health,
Vascular Diseases Research; 93.838, Lung Bioengineering, 6701 Democracy Blvd.,
Building 38A, 8600 Rockville Pike, Bethesda,
Diseases Research; 93.839, Blood Diseases Room 241, Bethesda, MD 20892.
MD 20892. (Telephone Conference Call). and Resources Research, National Institutes Any interested person may file written
Contact Person: Roy L. White, PhD., of Health, HHS) comments with the committee by forwarding
Division of Extramural Affairs, Review
Dated: December 14, 2005. the statement to the Contact Person listed on
Branch, National Heart, Lung, and Blood
Anna Snouffer, this notice. The statement should include the
Institute, NIH, 6701 Rockledge Drive, Room
Acting Director, Office of Federal Advisory name, address, telephone number and when
7202, Bethesda, MD 20892–7924. 301/435–
Committee Policy. applicable, the business or professional
0310. whiterl@mail.nih.gov.
[FR Doc. 05–24381 Filed 12–21–05; 8:45 am] affiliation of the interested person.
This notice is being published less than 15
Information is also available on the
days prior to the meeting due to the timing BILLING CODE 4140–01–M
Institute’s/Center’s home page: http://
limitations imposed by the review and
www.nibib1.nih.gov/about/NACBIB/
funding cycle.
DEPARTMENT OF HEALTH AND NACBIB.htm, where an agenda and any
(Catalogue of Federal Domestic Assistance additional information for the meeting will
Program Nos. 93.233, National Center for HUMAN SERVICES
be posted when available.
Sleep Disorders Research; 93.837, Heart and
National Institutes of Health Dated: December 15, 2005.
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases National Institute of Biomedical Anna Snouffer,
and Resources Research, National Institutes Imaging and Bioengineering; Notice of Acting Director, Office of Federal Advisory
of Heath, HHS). Meeting Committee Policy.
Dated: December 14, 2005. [FR Doc. 05–24376 Filed 12–21–05; 8:45 am]
Pursuant to section 10(d) of the
cchase on PROD1PC60 with NOTICES

Anna Snouffer, Federal Advisory Committee Act, as BILLING CODE 4140–01–M

Acting Director, Office of Federal Advisory amended (5 U.S.C. Appendix 2), notice
Committee Policy. is hereby given of a meeting of the
[FR Doc. 05–24378 Filed 12–21–05; 8:45 am] National Advisory Council for
BILLING CODE 4140–01–M Biomedical Imaging and Bioengineering.

VerDate Aug<31>2005 16:55 Dec 21, 2005 Jkt 208001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\22DEN1.SGM 22DEN1

Você também pode gostar